Award
Award #75N93026D00016
Long-Term IDV Contract for Antimicrobial Activity Evaluation by MRIGlobal
Buyer
National Institutes of Health
Award Amount
$2,500.00
Ceiling
$2,500.00
Awarded
September 30, 2026
Period of Performance
Sep 30, 2026 – Sep 29, 2036
Identifier
75N93026D00016
NAICS
541714
This award is a long-term indefinite delivery vehicle (IDV) contract granted to MRIGlobal, a non-profit scientific research organization known for its biomedical and chemical research expertise. The contract focuses on in vitro assessments of antimicrobial activity, providing essential laboratory testing services that support public health initiatives and scientific research. This multi-year agreement, spanning approximately a decade, plays a crucial role in advancing antimicrobial research, bolstering government efforts in health security and disease control. The scope includes conducting detailed laboratory experiments to evaluate the effectiveness of various antimicrobial agents. The contract was secured through a competitive bidding process adhering to federal acquisition standards, ensuring a fair and open selection of qualified providers. No subcontractors or additional solicitation details were reported for this award.
Description
IN VITRO ASSESSMENT OF ANTIMICROBIAL ACTIVITY (IVAAA)